Clinical Trial: Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
Study Status: Completed
Recruit Status: RECRUITING
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: A First in Human, Single Center, Single Dose, Randomized, Placebo-controlled, Dose, Escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administe
Brief Summary:
Single center, single-dose, randomized, placebo-controlled, dose-escalating study to evaluate, safety, tolerability, pharmacokinetics, and pharmacodynamics of escalating doses of ENT-03S in obese but otherwise healthy subjects and in subjects with obesity and Type 2 diabetes.
Read more